Lung Infection Pseudomonal
2 clinical trials · Condition
◉ Watch Lung Infection Pseudomonal
| Record | Firm | Date |
|---|---|---|
| Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis (NCT04596319) | Armata Pharmaceuticals, Inc. | 2020-12-22 |
| A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis (NCT03309358) | Synspira, Inc. | 2017-09-28 |
Track Lung Infection Pseudomonal automatically
Every clearance here is in the API, with alerts when new ones post.